Carpal Tunnel SyndromeNCT06191003
Urdu Version of Maastricht Upper Extremity Questionnaire Reliability Validity Study.
An observational study of Carpal Tunnel Syndrome, run by Riphah International University at 1 site in Pakistan.
Trial summary
In this study, the examiners will investigate the reliability and validity of Mastrict Upper Extremity scale in Urdu language in Pakistani patients with Carpal tunnel syndrome. Read more about this study
- Who is it for?
- Ages 18 to 50 years
- Conditions the study is for
- Carpal Tunnel Syndrome
- How many people
- 135 participants
- Where
- 1 sitePakistan
- Study dates
- 1 May 2021to 28 Apr 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- No healthy volunteers
- Adult
Study population: Pakistani computer user's population with complaint of arm, neck, shoulder (CANS) was included in this study.
Who may be able to join
- Individuals who had to execute computer jobs in office.
- Individuals who have been working in present position for minimum 6 months
- Individuals who have been working for at least 4 hours or more in a day
Who cannot join
- Individuals who had Severe phsycytric and behavioral complaint
- Individuals who had prior injury of upper extremity
- Individuals who had any surgery of upper extremity
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Riphah International University
Faisalabad, Punjab Province, 38000
About this study
Official title: Analysis of Urdu Version of Maastricht Upper Extremity Questionnaire: A Reliability and Validity Study.
In this study, the examiners will investigate the reliability and validity of Mastrict Upper Extremity scale in Urdu language in Pakistani patients with Carpal tunnel syndrome.
Read the detailed description
The objective of this study is to translate as well as culturally adapt the Mastrict Upper Extrimity scale (MUEQ) into Urdu language and to test its reliability and validity in patients with Carpal Tunnel Syndrome. This cross-sectional survey will use convenience sampling technique to enroll the participants on a pre-defined criteria.
The outcomes of this study will help in finding the reliability and validity of MUEQ in patients with CTS. The reliability of this scale will be examined using internal consistency and test-retest methods. The internal consistency will be checked by Cronbach's alpha value. The test-retest reliability will be analyzed using an interclass correlation with patients.
- Conditions
- Carpal Tunnel Syndrome
- Medical subject headings
- Carpal Tunnel Syndrome
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analouge scale
The visual analogue scale is a simple and frequently used method for the assessment of variations in intensity of pain. In clinical practice the percentage of pain relief, assessed by Visual Analouge scale, is often considered as a measure of the efficacy of treatment.
Measured: 12th week
JAMAR Hydraulic hand Dynamometer
Hand grip strength is an indicator of general muscle strength that is measured using a hand dynamometer.
Measured: 12th week
Boston questionnaire
The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome.
Measured: 12th week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2024
- Study start1 May 2021
- Primary completion28 Apr 2023
- Study completion28 Apr 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Carpal Tunnel SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 135 participants (actual)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Muhammad Kashif, Study chair, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06191003
- Sponsor's protocol ID
- REC-FSD-00249
- Status last verified
- Dec 2023
- First submitted
- 19 Dec 2023
- Last updated
- 5 Jan 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analysis of Urdu Version of Maastricht Upper Extremity Questionnaire: A Reliability and Validity Study.
- ClinicalTrials.gov ID
- NCT06191003
- Acronym / sponsor ID
- REC-FSD-00249
- Conditions
- Carpal Tunnel Syndrome
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 135 participants (actual)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 1 May 2021 (actual)
- Primary completion
- 28 Apr 2023 (actual)
- Study completion
- 28 Apr 2023 (actual)
- First posted
- 5 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, the examiners will investigate the reliability and validity of Mastrict Upper Extremity scale in Urdu language in Pakistani patients with Carpal tunnel syndrome.
Detailed description
The objective of this study is to translate as well as culturally adapt the Mastrict Upper Extrimity scale (MUEQ) into Urdu language and to test its reliability and validity in patients with Carpal Tunnel Syndrome. This cross-sectional survey will use convenience sampling technique to enroll the participants on a pre-defined criteria.
The outcomes of this study will help in finding the reliability and validity of MUEQ in patients with CTS. The reliability of this scale will be examined using internal consistency and test-retest methods. The internal consistency will be checked by Cronbach's alpha value. The test-retest reliability will be analyzed using an interclass correlation with patients.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Pakistani computer user's population with complaint of arm, neck, shoulder (CANS) was included in this study.
Key inclusion criteria (3 listed)
- Individuals who had to execute computer jobs in office.
- Individuals who have been working in present position for minimum 6 months
- Individuals who have been working for at least 4 hours or more in a day
Key exclusion criteria (3 listed)
- Individuals who had Severe phsycytric and behavioral complaint
- Individuals who had prior injury of upper extremity
- Individuals who had any surgery of upper extremity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Visual Analouge scale
Time frame: 12th week
The visual analogue scale is a simple and frequently used method for the assessment of variations in intensity of pain. In clinical practice the percentage of pain relief, assessed by Visual Analouge scale, is often considered as a measure of the efficacy of treatment.
JAMAR Hydraulic hand Dynamometer
Time frame: 12th week
Hand grip strength is an indicator of general muscle strength that is measured using a hand dynamometer.
Boston questionnaire
Time frame: 12th week
The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jan 2024.
- Individual participant dataSharing planned: No
Related trials for Carpal Tunnel Syndrome
Recruiting
Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS) Post-burn
Not yet recruitingObservational study
Symptom Recovery Time After the Phalen Test in Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS)
Recruiting
Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome
Carpal Tunnel Syndrome
Recruiting
Finnish Carpal Tunnel Surgery Study
Carpal Tunnel Syndrome
Recruiting
Effects of Peripheral Repetitive Peripheral Magnetic Stimulation on Individuals With Elbow or Wrist Chronic Pain
Tennis Elbow Syndrome, Golfer's Elbow
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Muhammad Kashif study chair
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Carpal Tunnel Syndrome, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analouge scale (time frame: 12th week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2024; AzTrials last refreshed its copy on 30 Oct 2026.